Global Meropenem Injection Market Size, Share and Trends Analysis Report, By Product Type (0.25 g/vial, 0.5 g/vial, and 1 g/vial), By Application (Hospitals, Clinics, and Others), Forecast (2022-2028)

The global meropenem injection market is anticipated to grow at a CAGR of nearly 5.0% during the forecast period (2022-2028). Meropenem injection is used to treat a variety of bacterial infections, including meningitis, pneumonia, and so on. The major factor expected to drive the market growth is the rising prevalence of infectious diseases, such as pneumonia, malaria, stomach infections, lower respiratory infections, and tuberculosis. Moreover, due to the surge in disease burden governments and non-governmental organizations have been investing in R&D to accelerate the development of novel antibiotics and formulate supportive regulatory policies to expedite the approval process. The research funding along with the increasing effort of pharmaceutical companies for the development of novel therapies to treat infectious diseases will further drive the global meropenem injection market during the forecast period.

It is also used to treat streptococci, E. coli, klebsiella pneumonia, pseudomonas aeruginosa, and bacteroides fragilis, and pepto streptococcus species as a single agent therapy. In addition, the rise in the prevalence of bacterial infections and the increase in the need for more effective and newer antibiotics also propel the growth of the global meropenem injection market. As per the data by World Health Organization (WHO) in 2019, 10 million people globally were infected with tuberculosis and 1.4 million people succumbed to the disease. A study also shows that infectious diseases are emerging due to urbanization, destruction of natural habitats, climate change, and changing ecosystems.

Additionally, Asia Pacific meropenem market is expected to grow at a rapid pace owing to the rise in the prevalence of skin and abdominal infections caused by bacteria and meningitis. Some major players in the market include Amneal Pharmaceutical Inc., Fresenius Kabi AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape- Amneal Pharmaceutical Inc., Fresenius Kabi AG, and Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Meropenem Injection Market Report by Segment

By Product Type

• 25 g/vial
• 5 g/vial
• 1 g/via

By Application

• Hospitals
• Clinics
• Others

Global Meropenem Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa